'Ecstasy' enhances noise-induced hearing loss

Hearing Research

Volumn 302, Issue , 2013, Pages 96-106

  Church, Michael W ^a,b   Zhang, Jinsheng S ^a,b   Langford, Megan M ^a   Perrine, Shane A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ACOUSTIC STRESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; COCHLEA; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; MALE; NOISE INJURY; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RAT;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; AUDITORY THRESHOLD; BODY TEMPERATURE; COCHLEA; EDETIC ACID; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HAIR CELLS, AUDITORY, INNER; HAIR CELLS, AUDITORY, OUTER; HEARING LOSS, NOISE-INDUCED; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NOISE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84879424032     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2013.05.007     Document Type: Article

References (75)

1. Alvarado J.C., Fuentes-Santamaria V., Jareno-Flores T., Blanco J.L., Juiz J.M. Normal variations in the morphology of auditory brainstem response (ABR) waveforms: a study in Wistar rats. Neurosci. Res. 2012, 73:302-311.
2. Baker K.E., Herbert A.A., Broadley K.J. Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect. Vascul Pharmacol. 2007, 47:10-17.
3. Biezonski D.K., Meyer J.S. The nature of 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonergic dysfunction: evidence for and against the neurodegeneration hypothesis. Curr. Neuropharmacol. 2011, 9:84-90.
4. Bingham C., Beaman M., Nicholls A.J., Anthony P.P. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy'). Nephrol. Dial. Transplant. 1998, 13:2654-2655.
5. Chen C.J., Dai Y.T., Sun Y.M., Lin Y.C., Juang Y.J. Evaluation of auditory fatigue in combined noise, heat and workload exposure. Ind. Health 2007, 45:527-534.
6. Chen G.D., Henderson D. Cochlear injuries induced by the combined exposure to noise and styrene. Hear. Res. 2009, 254:25-33.
7. Chen T.J., Chen S.S. Generator study of brainstem auditory evoked potentials by a radiofrequency lesion method in rats. Exp. Brain Res. 1991, 85:537-542.
8. Church M.W., Williams H.L., Holloway J.A. Postnatal development of the brainstem auditory evoked potential and far-field cochlear microphonic in non-sedated rat pups. Brain Res. 1984, 316:23-31.
9. Church M.W., Blakley B.W., Burgio D.L., Gupta A.K. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. J.Assoc. Res. Otolaryngol. 2004, 5:227-237.
10. Church M.W., Hotra J.W., Holmes P.A., Anumba J.I., Jackson D.A., Adams B.R. Auditory brainstem response (ABR) abnormalities across the life span of rats prenatally exposed to alcohol. Alcohol. Clin. Exp. Res. 2012, 36:83-96.
11. Cody A.R., Robertson D. Variability of noise-induced damage in the guinea pig cochlea: electrophysiological and morphological correlates after strictly controlled exposures. Hear. Res. 1983, 9:55-70.
12. Dafters R.I., Duffy F., O'Donnell P.J., Bouquet C. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence. Psychopharmacology (Berl) 1999, 145:82-90.
13. Darvesh A.S., Yamamoto B.K., Gudelsky G.A. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. J.Pharmacol. Exp. Ther. 2005, 312:694-701.
14. Dehmel S., Eisinger D., Shore S.E. Gap prepulse inhibition and auditory brainstem-evoked potentials as objective measures for tinnitus in guinea pigs. Front. Syst. Neurosci. 2012, 6:1-15.
15. Elgoyhen A.B., Katz E., Fuchs P.A. The nicotinic receptor of cochlear haircells: a possible pharmacotherapeutic target?. Biochem. Pharmacol. 2009, 78:712-719.
16. Feduccia A.A., Duvauchelle C.L. Auditory stimuli enhance MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin and locomotor responses. Brain Res. Bull. 2008, 77:189-196.
17. Fiaschi A.I., Cerretani D. Causes and effects of cellular oxidative stress as a result of MDMA abuse. Curr. Pharm. Biotechnol. 2010, 11:444-452.
18. Fischer C., Hatzidimitriou G., Wlos J., Katz J., Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J.Neurosci. 1995, 15:5476-5485.
19. Gamma A., Frei E., Lehmann D., Pascual-Marqui R.D., Hell D., Vollenweider F.X. Mood state and brain electric activity in ecstasy users. Neuroreport 2000, 11:157-162.
20. Garcia-Rates S., Camarasa J., Sanchez-Garcia A.I., Gandia L., Escubedo E., Pubill D. The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation. Toxicol. Appl. Pharmacol. 2010, 244:344-353.
21. Gesi M., Soldani P., Lenzi P., Ferrucci M., Giusiani A., Fornai F., Paparelli A. Ecstasy during loud noise exposure induces dramatic ultrastructural changes in the heart. Pharmacol. Toxicol. 2002, 91:29-33.
22. Gesi M., Ferrucci M., Giusiani M., Lenzi P., Lazzeri G., Alessandri M.G., Salvadorini A., Fulceri F., Pellegrini A., Fornai F., Paparelli A. Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice. Microsc. Res. Tech. 2004, 64:297-303.
23. Gourevitch B., Doisy T., Avillac M., Edeline J.M. Follow-up of latency and threshold shifts of auditory brainstem responses after single and interrupted acoustic trauma in guinea pig. Brain Res. 2009, 1304:66-79.
24. Gratton M.A., Salvi R.J., Kamen B.A., Saunders S.S. Interaction of cisplatin and noise on the peripheral auditory system. Hear. Res. 1990, 50:211-223.
25. Green A.R., King M.V., Shortall S.E., Fone K.C. Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans. Br. J. Pharmacol. 2012, 166:1523-1536.
26. Greenhouse S.W., Geisser S. On methods in the analysis of profile data. Psychometrika 1959, 24:95-112.
27. Gunderson E., Moline J., Catalano P. Risks of developing noise-induced hearing loss in employees of urban music clubs. Am. J. Ind. Med. 1997, 31:75-79.
28. Hemmerle A.M., Dickerson J.W., Herring N.R., Schaefer T.L., Vorhees C.V., Williams M.T., Seroogy K.B. (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain. J.Comp. Neurol. 2012, 520:2459-2474.
29. Henry K.R. Auditory brainstem volume-conducted responses: origins in the laboratory mouse. J.Am. Aud. Soc. 1979, 4:173-178.
30. Henry K.R. Hyperthermia exacerbates and hypothermia protects from noise-induced threshold elevation of the cochlear nerve envelope response in the C57BL/6J mouse. Hear. Res. 2003, 179:88-96.
31. Hoet P., Lison D. Ototoxicity of toluene and styrene: state of current knowledge. Crit. Rev. Toxicol. 2008, 38:127-170.
32. Hood L.I. Clinical Applications of the Auditory Brainstem Response Singular 1998, 50-51. Publishing Group, Inc., San Diego, 67-124.
33. Hurley L.M., Hall I.C. Context-dependent modulation of auditory processing by serotonin. Hear. Res. 2011, 279:74-84.
34. Hyde M.L. Signal processing and analysis. Principles & Applications in Auditory Evoked Potentials 1993, 47-84. (Chapter 3), Allyn and Bacon, Boston. J.T. Jacobson (Ed.).
35. Institute of Laboratory Animal Resources (U.S.).Committee on Care and Use of Laboratory Animals Guide for the Care and Use of Laboratory Animals 2011, v. U.S. Dept. of Health and Human Services, Public Health Service, Bethesda, Md, NIH Publication.
36. Jin D.X., Lin Z., Lei D., Bao J. The role of glucocorticoids for spiral ganglion neuron survival. Brain Res. 2009, 1277:3-11.
37. Johnson B.N., Yamamoto B.K. Chronic stress enhances the corticosterone response and neurotoxicity to+3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature. J.Pharmacol. Exp. Ther. 2010, 335:180-189.
38. Johnson E.A., O'Callaghan J.P., Miller D.B. Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse. Brain Res. 2002, 933:130-138.
39. Johnston L.D., O'Malley P.M., Bachman J.G., Scheulenberg J.E. Monitoring the future national survey results on drug use, 1975-2010. Secondary School Students 2010 2011, vol. I:24-25. National Institute on Drug Abuse, Bethesda, MD (USA).
40. Kay C., Harper D.N., Hunt M. The effects of binge MDMA on acquisition andreversal learning in a radial-arm maze task. Neurobiol. Learn. Mem. 2011, 95:473-483.
41. Kujawa S.G., Liberman M.C. Adding insult to injury: cochlear nerve degeneration after "temporary" noise-induced hearing loss. J.Neurosci. 2009, 29:14077-14085.
42. Le Prell C.G., Yamashita D., Minami S.B., Yamasoba T., Miller J.M. Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hear. Res. 2007, 226:22-43.
43. Lendvai B., Halmos G.B., Polony G., Kapocsi J., Horvath T., Aller M., Sylvester Vizi E., Zelles T. Chemical neuroprotection in the cochlea: the modulation of dopamine release from lateral olivocochlear efferents. Neurochem. Int. 2011, 59:150-158.
44. Li H., Steyger P.S. Synergistic ototoxicity due to noise exposure and aminoglycoside antibiotics. Noise Health 2009, 11:26-32.
45. Manzoor N., Licari F.G., Klapchar M., Elkin R., Gao Y., Kaltenbach J.A. Noise-induced hyperactivity in the inferior colliculus: its relationship with hyperactivity in the dorsal cochlear nucleus. J.Neurophysiol. 2012, 108:976-988.
46. Mithoefer M.C., Wagner M.T., Mithoefer A.T., Jerome L., Martin S.F., Yazar-Klosinski B., Michel Y., Brewerton T.D., Doblin R. Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J.Psychopharmacol. 2013, 27:28-39.
47. Moller A.R., Jho H.D., Yokota M., Jannetta P.J. Contribution from crossed and uncrossed brainstem structures to the brainstem auditory evoked potentials: a study in humans. Laryngoscope 1995, 105:596-605.
48. Morton A.J., Hickey M.A., Dean L.C. Methamphetamine toxicity in mice is potentiated by exposure to loud music. Neuroreport 2001, 12:3277-3281.
49. Muller M. Frequency representation in the rat cochlea. Hear. Res. 1991, 51:247-254.
50. Obrocki J., Buchert R., Vaterlein O., Thomasius R., Beyer W., Schiemann T. Ecstasy - long-term effects on the human central nervous system revealed by positron emission tomography. Br. J. Psychiatry 1999, 175:186-188.
51. Papesh M.A., Hurley L.M. Plasticity of serotonergic innervation of the inferior colliculus in mice following acoustic trauma. Hear. Res. 2012, 283:89-97.
52. Perrine S.A., Michaels M.S., Ghoddoussi F., Hyde E.M., Tancer M.E., Galloway M.P. Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. NMR Biomed. 2009, 22:419-425.
53. Perrine S.A., Ghoddoussi F., Michaels M.S., Hyde E.M., Kuhn D.M., Galloway M.P. MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain. Neurotoxicology 2010, 31:654-661.
54. Piper B.J., Fraiman J.B., Owens C.B., Ali S.F., Meyer J.S. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Neuropsychopharmacology 2008, 33:1192-1205.
55. Rawool V., Dluhy C. Auditory sensitivity in opiate addicts with and without a history of noise exposure. Noise Health 2011, 13:356-363.
56. Rossi G.T., Britt R.H. Effects of hypothermia on the cat brain-stem auditory evoked response. Electroencephalogr. Clin. Neurophysiol. 1984, 57:143-155.
57. Sadhra S., Jackson C.A., Ryder T., Brown M.J. Noise exposure and hearing loss among student employees working in university entertainment venues. Ann. Occup. Hyg. 2002, 46:455-463.
58. Santos M.A., Munhoz M.S., Peixoto M.A., Silva C.S. High click stimulus repetition rate in the auditory evoked potentials in multiple sclerosis patients with normal MRI. Does it improve diagnosis?. Rev. Laryngol. Otol. Rhinol. (Bord) 2004, 125:151-155.
59. Sarkar S., Schmued L. Neurotoxicity of ecstasy (MDMA): an overview. Curr. Pharm. Biotechnol. 2010, 11:460-469.
60. Serra M.R., Biassoni E.C., Richter U., Minoldo G., Franco G., Abraham S., Carignani J.A., Joekes S., Yacci M.R. Recreational noise exposure and its effects on the hearing of adolescents. Part I: an interdisciplinary long-term study. Int. J. Audiol. 2005, 44:65-73.
61. Shah S.N., Salamy A. Failure of 5-hydroxytryptophan to modulate brain stem auditory evoked responses in myelin deficient mutant qk mice. Exp. Neurol. 1984, 86:160-164.
62. Sharma A. Acase of sensorineural deafness following ingestion of Ecstasy. J.Laryngol. Otol. 2001, 115:911-915.
63. Starr A., Sininger Y., Nguyen T., Michalewski H.J., Oba S., Abdala C. Cochlear receptor (microphonic and summating potentials, otoacoustic emissions) and auditory pathway (auditory brain stem potentials) activity in auditory neuropathy. Ear Hear. 2001, 22:91-99.
64. Taffe M.A., Huitron-Resendiz S., Schroeder R., Parsons L.H., Henriksen S.J., Gold L.H. MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys. Pharmacol. Biochem. Behav. 2003, 76:141-152.
65. Taffe M.A., Weed M.R., Davis S., Huitron-Resendiz S., Schroeder R., Parsons L.H., Henriksen S.J., Gold L.H. Functional consequences of repeated (±)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neuropsychopharmacology 2001, 24:230-239.
66. Tanaka F., Whitworth C.A., Rybak L.P. Influence of pH on the ototoxicity of cisplatin: a round window application study. Hear. Res. 2003, 177:21-31.
67. Tannahill J.C., Smoski W.J. Introduction to the management of the hearing impaired. Handbook of Clinical Audiology 1982, 442-446. Williams & Wilkins, Baltimore. second ed. J. Katz (Ed.).
68. Tong L., Altschuler R.A., Holt A.G. Tyrosine hydroxylase in rat auditory midbrain: distribution and changes following deafness. Hear. Res. 2005, 206:28-41.
69. Vanattou-Saifoudine N., McNamara R., Harkin A. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats. Br. J. Pharmacol. 2010, 160:860-877.
70. Vlajkovic S.M., Housley G.D., Thorne P.R. Adenosine and the auditory system. Curr. Neuropharmacol. 2009, 7:246-256.
71. Wang Y., Hirose K., Liberman M.C. Dynamics of noise-induced cellular injury and repair in the mouse cochlea. J.Assoc. Res. Otolaryngol. 2002, 3:248-268.
72. Weir E. Raves: a review of the culture, the drugs and the prevention of harm. CMAJ 2000, 162:1843-1848.
73. Williams W., Beach E.F., Gilliver M. Clubbing: the cumulative effect of noise exposure from attendance at dance clubs and night clubs on whole-of-life noise exposure. Noise Health 2010, 12:155-158.
74. Yau J.L., Kelly P.A., Sharkey J., Seckl J.R. Chronic 3,4-methylenedioxymethamphetamine administration decreases glucocorticoid and mineralocorticoid receptor, but increases 5-hydroxytryptamine1C receptor gene expression in the rat hippocampus. Neuroscience 1994, 61:31-40.
75. Zhang J.S., Kaltenbach J.A., Godfrey D.A., Wang J. Origin of hyperactivity in the hamster dorsal cochlear nucleus following intense sound exposure. J.Neurosci. Res. 2006, 84:819-831.